Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression

Abstract

Colitis is a form of inflammatory bowel disease characterized by chronic inflammation of the colon. In this study, we investigated the therapeutic potential of Δ8-tetrahydrocannabinol (Δ8-THC), a cannabinoid with lower psychoactive potency than the well-characterized Δ9-THC, in murine models of colitis. Colitis was induced with dextran sulfate sodium (DSS) in C57BL/6J mice or 2,4,6-trinitrobenzenesulfonic acid (TNBS) in BALB/c mice, and Δ8-THC was administered intraperitoneally at 20 mg/kg. Treatment with Δ8-THC significantly attenuated disease severity, as evidenced by improved colonoscopic findings and restoration of colon length. At the cellular level, Δ8-THC reduced the infiltration of myeloid cells and shifted macrophage polarization from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 phenotype. Exploratory miRNA sequencing in colonic samples identified alterations in regulatory miRNAs, with mmu-let-7a-5p emerging as a key candidate. Differential expression of let-7a-5p was validated by qPCR. In the RAW 264.7 macrophage cell line, mimic and inhibitor experiments showed that manipulation of let-7a-5p modulated Cd86 transcript levels. Computational analyses predicted a potential let-7a-5p–Cd86 interaction. Together, these findings demonstrate that Δ8-THC attenuates colitis, which is associated with increased let-7a-5p expression in the colon, and support a potential role for this miRNA in regulating macrophage-associated inflammatory responses.

Related

  1. Apigenin Attenuates Lipopolysaccharide-Induced Endothelial Activation and Injury-Associated Phenotypes in Human Umbilical Vein Endothelial Cells
    Jinjuan Wen, Sihao Hong, Jiaman Lai +3
    Journal of Inflammation ResearchPeer-reviewedCC BY-NC 4.0Full textPharmacology & toxicologyPMCEurope PMC
  2. hiPSC Extract Attenuates Senescence-Associated Phenotypes in AB-MSCs In Vitro
    Yuanyuan Pan, Lumiao Zhang, Rongyuan Zhu +2
    CellsPeer-reviewedCC BY 4.0Human geneticsCrossref
  3. Epigenetic Silencing of ZNF471 Contributes to Osimertinib Resistance in Lung Adenocarcinoma: β-Hydroxybutyrate Associates with ZNF471 Re-Expression and Reduced Resistance-Associated Phenotypes
    Dade Feng, Huiting Yan, Qian Ni +4
    Oncology ResearchPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  4. Small-molecule ACOD1 inhibition attenuates colitis and tumor growth through a shared myeloid mechanism, diverging from genetic deletion
    A. E. Papathanassiu, W. Li, K. Gilbo +1
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  5. Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS‐Induced Colitis via Mucus Barrier Protection
    Marcela S. C. Brito, Anderson K. Taporosky, Katlin S. Rech +8
    Clinical and Experimental Pharmacology & PhysiologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
BibTeX
@article{garciasanchez2026delta8tetrahydrocannabinol,
  title = {{Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression}},
  author = {Jeffrey I. Garcia-Sanchez and Taylor H. Carter and Urmi Halder and Mitzi Nagarkatti and Prakash Nagarkatti},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = nov,
  doi = {10.3389/fphar.2026.1973874},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1973874},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Delta-8-tetrahydrocannabinol attenuates colitis and is associated with changes in myeloid cell phenotypes and let-7a-5p expression
AU  - Jeffrey I. Garcia-Sanchez
AU  - Taylor H. Carter
AU  - Urmi Halder
AU  - Mitzi Nagarkatti
AU  - Prakash Nagarkatti
PY  - 2026
DA  - 2026/11/13
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1973874
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1973874
AB  - Colitis is a form of inflammatory bowel disease characterized by chronic inflammation of the colon. In this study, we investigated the therapeutic potential of Δ8-tetrahydrocannabinol (Δ8-THC), a cannabinoid with lower psychoactive potency than the well-characterized Δ9-THC, in murine models of colitis. Colitis was induced with dextran sulfate sodium (DSS) in C57BL/6J mice or 2,4,6-trinitrobenzenesulfonic acid (TNBS) in BALB/c mice, and Δ8-THC was administered intraperitoneally at 20 mg/kg. Treatment with Δ8-THC significantly attenuated disease severity, as evidenced by improved colonoscopic findings and restoration of colon length. At the cellular level, Δ8-THC reduced the infiltration of myeloid cells and shifted macrophage polarization from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 phenotype. Exploratory miRNA sequencing in colonic samples identified alterations in regulatory miRNAs, with mmu-let-7a-5p emerging as a key candidate. Differential expression of let-7a-5p was validated by qPCR. In the RAW 264.7 macrophage cell line, mimic and inhibitor experiments showed that manipulation of let-7a-5p modulated Cd86 transcript levels. Computational analyses predicted a potential let-7a-5p–Cd86 interaction. Together, these findings demonstrate that Δ8-THC attenuates colitis, which is associated with increased let-7a-5p expression in the colon, and support a potential role for this miRNA in regulating macrophage-associated inflammatory responses.
SN  - 1663-9812
ER  -